| Product Code: ETC8858487 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Life Cycle |
3.4 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market - Porter's Five Forces |
3.5 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
4 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing RD investments in cancer immunotherapy |
4.2.2 Growing prevalence of cancer in Poland |
4.2.3 Advancements in technology and techniques for drug discovery |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug development |
4.3.2 High costs associated with outsourcing drug discovery |
4.3.3 Intellectual property protection concerns |
5 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Trends |
6 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market, By Types |
6.1 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Service Type, 2021- 2031F |
6.1.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Target Identification and Validation, 2021- 2031F |
6.1.4 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lead Screening and Characterization, 2021- 2031F |
6.1.5 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cell-based Assays, 2021- 2031F |
6.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Lung, 2021- 2031F |
6.2.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Breast, 2021- 2031F |
6.2.4 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Colorectal, 2021- 2031F |
6.2.5 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.2.6 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Prostate, 2021- 2031F |
6.2.7 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Head and Neck, 2021- 2031F |
6.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Immunomodulators, 2021- 2031F |
6.3.4 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenues & Volume, By Cancer Vaccines and Oncolytic Viral Therapy, 2021- 2031F |
7 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Import-Export Trade Statistics |
7.1 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Export to Major Countries |
7.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Imports from Major Countries |
8 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Key Performance Indicators |
8.1 Number of new partnerships and collaborations in cancer immunotherapy drug discovery outsourcing |
8.2 Percentage increase in the adoption of advanced technologies in drug discovery processes |
8.3 Time-to-market for cancer immunotherapy drugs discovered through outsourcing |
8.4 Number of patents filed for novel drug candidates discovered through outsourcing |
8.5 Rate of successful clinical trials for drugs discovered through outsourcing |
9 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market - Opportunity Assessment |
9.1 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market - Competitive Landscape |
10.1 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Revenue Share, By Companies, 2024 |
10.2 Poland Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here